Pooled efficacy and safety of eslicarbazepine acetate as add-on treatment in patients with focal-onset seizures: Data from four double-blind placebo-controlled pivotal phase III clinical studies.

MLA

Elger, Christian, et al. “Pooled Efficacy and Safety of Eslicarbazepine Acetate as Add-on Treatment in Patients with Focal-Onset Seizures: Data from Four Double-Blind Placebo-Controlled Pivotal Phase III Clinical Studies.” CNS Neuroscience & Therapeutics, vol. 23, no. 12, Dec. 2017, pp. 961–72. EBSCOhost, https://doi.org/10.1111/cns.12765.

APA

Elger, C., Koepp, M., Trinka, E., Villanueva, V., Chaves, J., Ben-Menachen, E., Kowacs, P. A., Gil-Nagel, A., Moreira, J., Gama, H., Rocha, J.-F., & Soares-da-Silva, P. (2017). Pooled efficacy and safety of eslicarbazepine acetate as add-on treatment in patients with focal-onset seizures: Data from four double-blind placebo-controlled pivotal phase III clinical studies. CNS Neuroscience & Therapeutics, 23(12), 961–972. https://doi.org/10.1111/cns.12765

Chicago

Elger, Christian, Mathias Koepp, Eugen Trinka, Vicente Villanueva, João Chaves, Elinor Ben-Menachen, Pedro A Kowacs, et al. 2017. “Pooled Efficacy and Safety of Eslicarbazepine Acetate as Add-on Treatment in Patients with Focal-Onset Seizures: Data from Four Double-Blind Placebo-Controlled Pivotal Phase III Clinical Studies.” CNS Neuroscience & Therapeutics 23 (12): 961–72. doi:10.1111/cns.12765.